Position in NTRA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$6,243
+$3,444 QoQ
Shares Held
23
+64.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#773
of 844 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bogart Wealth, LLC holds $375,837 across 17 Diagnostics & Research names. NTRA ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
201 | $100,773 | |
| 2 | DHR |
Danaher Corp /De/
|
503 | $95,811 | |
| 3 | WAT |
Waters Corp /De/
|
185 | $69,382 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
140 | $27,050 | |
| 5 | ILMN |
Illumina, Inc.
|
86 | $15,121 | |
| 6 | LH |
Labcorp Holdings Inc.
|
35 | $9,800 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
18 | $9,475 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
37 | $8,391 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,243 | 23 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,799 | 14 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,519 | 11 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,770 | 11 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $675 | 4 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $565 | 4 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||